| Literature DB >> 28433939 |
Wei Du1, Kaiyue Zhang1, Shuaiqiang Zhang1, Ran Wang1, Yan Nie1, Hongyan Tao1, Zhibo Han2, Lu Liang2, Di Wang1, Jianfeng Liu3, Na Liu1, Zhongchao Han2, Deling Kong4, Qiang Zhao5, Zongjin Li6.
Abstract
Mesenchymal stem cell (MSC)-derived exosomes have been recognized as new candidates for the treatment of degenerative diseases or injury and may provide an alternative to cell-based therapy. However, the compositions in MSC-derived exosomes are highly influenced by the microenvironment in which their original cells reside. Here, we hypothesized that a nitric oxide (NO)-releasing polymer can boost the proangiogenic compositions of exosomes and enhance their proangiogenic capacity. Our results demonstrated that exosomes, released from human placenta-derived MSCs (hP-MSCs) by NO stimulation, augment the angiogenic effects of human umbilical vein endothelial cells (HUVECs) in vitro. Moreover, exosomes released from hP-MSCs by NO stimulation revealed superior angiogenic effects and ameliorated limb function in a murine model of hind limb ischemia. Further analysis demonstrated that increased VEGF and miR-126 levels in exosomes released from hP-MSCs by NO stimulation were identified as a novel mechanism contributing to the increased capacity of these exosomes to promote angiogenic processes. In conclusion, designing specific microenvironments for in vitro stem cell culture, such as those containing bioactive material, will facilitate the development of customized exosomes encapsulating a beneficial composition of stem cells for cell-free therapeutic applications.Entities:
Keywords: Angiogenesis; Exosome; Mesenchymal stem cell(MSC); Nitric oxide; Vascular endothelial growth factor (VEGF); miR-126
Mesh:
Substances:
Year: 2017 PMID: 28433939 DOI: 10.1016/j.biomaterials.2017.04.030
Source DB: PubMed Journal: Biomaterials ISSN: 0142-9612 Impact factor: 12.479